Skip to main content

Atomoxetine use while Breastfeeding

Medically reviewed by Drugs.com. Last updated on Sep 8, 2021.

Drugs containing Atomoxetine: Strattera

Atomoxetine Levels and Effects while Breastfeeding

Summary of Use during Lactation

There is no published experience with atomoxetine during breastfeeding, although reports from the manufacturer found no serious adverse effects in two breastfed infants. An alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

The author of a review article reported that the manufacturer of atomoxetine (Eli Lilly and Co.) had reports of 2 infants who slept longer than usual after being breastfed by mothers who were taking atomoxetine. Neither of the infants experienced any serious adverse events. Dosages, duration of maternal therapy, infant age and extent of breastfeeding were not provided.[1]

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Amphetamine, Methylphenidate

References

1.
Besag FM. ADHD treatment and pregnancy. Drug Saf. 2014;37:397–408. [PubMed: 24794209]

Substance Identification

Substance Name

Atomoxetine

CAS Registry Number

83015-26-3

Drug Class

Breast Feeding

Lactation

Adrenergic Uptake Inhibitors

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.